MUUTAA Inc. is a private healthcare AI company focused on improving operational efficiencies for our partners throughout the Rx medication development and delivery chain. MUUTAA envisions a world where medication reaches the consumer with speed, precision, and sustainable simplicity
MUUTAA democratizes the use of artificial intelligence through integration into standard operational workflows. The technological benefits can now be leveraged to solve real-world medication issues and positively impact patient care
Through the application of artificial intelligence, we transform data into dynamic knowledge to improve patient outcomes and operational efficiencies for our partners in the medication development and delivery chain
MUUTAA envisions a world where medication reaches the consumer
with speed, precision, and sustainable simplicity
"Polypharmacy is widespread and increasingly common, occurring in primary and secondary care, and in care homes for older people. It has become a global issue, particularly, although not exclusively, in Western countries."
"Annually in the United States, medication nonadherence accounts for 125,000 deaths, 11% of hospitalizations, and $100 billion to $300 billion in additional spending."
Medication Trial Recruitment
"80% of medication trials fail to meet recruitment criteria. Only 5% of eligible patients are aware of medication trials."
“Patients were more commonly reported to have increased out of pocket costs, rates of drug errors, adverse events, mortality, and complaints during times of shortage. There were also reports of equivalent and improved patient outcomes in some cases.”